Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 8:04 pm Sale |
2024-12-31 | 13G | Zymeworks Inc. ZYME |
Redmile Group LLC | 4,840,463 7.000% |
-261,448 (-5.12%) |
Filing History |
| 2025-02-14 8:03 pm Purchase |
2024-12-31 | 13G | Silence Therapeutics plc SLN |
Redmile Group LLC | 7,197,951 5.100% |
7,197,951 (New Position) |
Filing History |
| 2025-02-14 8:03 pm Purchase |
2024-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 9,885,124 9.900% |
1,583,937 (+19.08%) |
Filing History |
| 2025-02-14 8:02 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 13,932,449 9.900% |
10,155,602 (+268.89%) |
Filing History |
| 2025-02-14 8:01 pm Sale |
2024-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 2,895,478 4.800% |
-302,013 (-9.45%) |
Filing History |
| 2025-02-14 8:01 pm Purchase |
2024-12-31 | 13G | Neurogene Inc. NGNE |
Redmile Group LLC | 1,479,766 9.900% |
429,462 (+40.89%) |
Filing History |
| 2025-02-14 8:00 pm Purchase |
2024-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Redmile Group LLC | 13,163,457 8.200% |
3,028,069 (+29.88%) |
Filing History |
| 2025-02-14 8:00 pm Sale |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 14,184,495 4.600% |
-1,191,702 (-7.75%) |
Filing History |
| 2024-12-26 9:00 pm Purchase |
2024-12-20 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 17,816,634 14.900% |
197,539 (+1.12%) |
Filing History |
| 2024-12-06 9:03 pm Sale |
2024-12-04 | 13D | Shattuck Labs, Inc. STTK |
Redmile Group LLC | 5,624,960 11.800% |
-39,932 (-0.70%) |
Filing History |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 15,376,197 5.100% |
-6,581,729 (-29.97%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Immunome, Inc. IMNM |
Redmile Group LLC | 4,889,554 8.100% |
1,010,139 (+26.04%) |
Filing History |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 810,245 2.800% |
-922,944 (-53.25%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,197,491 5.300% |
500,843 (+18.57%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 8,301,187 9.900% |
594,304 (+7.71%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 4,713,509 9.000% |
2,088,003 (+79.53%) |
Filing History |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Zymeworks Inc. ZYME |
Redmile Group LLC | 5,101,911 7.200% |
-688,319 (-11.89%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 15,669,217 16.200% |
340,900 (+2.22%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 6,970,307 9.900% |
1,948,421 (+38.80%) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 4,942,312 9.900% |
1,181,622 (+31.42%) |
Filing History |